To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. If you experience any issues with your products or services, please contact ATCC Customer Service at sales@atcc.org. For Technical questions please contact tech@atcc.org. Thank you.
X

Streptococcus agalactiae Lehmann and Neumann (ATCC® BAA-22-MINI-PACK)

Strain Designations: M781  /  Type Strain: no  /  Biosafety Level: 2

Permits and Restrictions

View Permits

Strain Designations M781
Application ATCC® BAA-22-MINI-PACK™ consists of 6 ready-to-use vials of ATCC® BAA-22™ frozen in 200 µL of glycerol stock, eliminating the need to rehydrate and culture the strain prior to use. Each vial is provided with a 2-D barcode for easy storage and tracking, as well as peel-off labels for fast and reliable recordkeeping.  Learn more about ATCC® MinisDeveloped by the leaders in microbial cultivation and preservation, ATCC® Minis provide a convenient, ready-to-use solution for handling quality control strains. ATCC® Minis are authenticated and backed by ATCC polyphasic testing – ensuring the same consistent and reliable reference materials you’ve come to trust for ATCC Genuine Cultures®. It is easy to ensure the quality of your products with ATCC® Minis – just open, plate, and go! .

Produces capsular polysaccharide type III
Isolation Cerebrospinal fluid of an infant with neonatal meningitis, 1978
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Antigenic Properties Serotype III
Product Format frozen
6 ready-to-use vials of ATCC® BAA-22™ in glycerol stock
Storage Conditions -70°C or colder, store upright. Storage at -20°C is acceptable for up to 1 year.
Preceptrol® no
Type Strain no
Antigenic Properties Serotype III
Name of Depositor CJ Baker
Special Collection NCRR Contract; ATCC® Minis
Isolation Cerebrospinal fluid of an infant with neonatal meningitis, 1978
References

Anderson DC, et al. Impaired chemotaxigenesis by type III group B streptococci in neonatal sera: relationship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement. Pediatr. Res. 17: 496-502, 1983. PubMed: 6348689

Kasper DL, et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J. Clin. Invest. 98: 2308-2314, 1996. PubMed: 8941648

BD MAX™ GBS Assay. BD Becton Dickinson.

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
Other Documentation